SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No.___2___)*
Exegenics Inc.
-----------------------------------------------------
(Name of Issuer)
Common Stock, $.01 par value
-------------------------------------------------------------
(Title of Class of Securities)
301610101
-----------------------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement [ ].
(A fee is not required only if the filing person: (1) has a previous statement
on file reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Check the appropriate box to designate the rule pursuant to which this Schedule
is filed:
[ ] Rule 13d-1(b)
[X] Rule 13d-1(c)
[ ] Rule 13d-1(d)
* The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities,
and for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 1 of 6 pages
CUSIP No. 301610101 13G Page 2 of 6 Pages
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
J. Morton Davis
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
United States
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 248,000
BENEFICIALLY --------------------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH 0
REPORTING --------------------------------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH 248,000
--------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
--------------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
359,400
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
2.1%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT
CUSIP No. 301610101 13G Page 3 of 6 Pages
--------------------------------------------------------------------------------
1 NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Rosalind Davidowitz
--------------------------------------------------------------------------------
2 CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP*
(a) [ ]
(b) [ ]
--------------------------------------------------------------------------------
3 SEC USE ONLY
--------------------------------------------------------------------------------
4 CITIZENSHIP OR PLACE OF ORGANIZATION
Delaware
--------------------------------------------------------------------------------
NUMBER OF 5 SOLE VOTING POWER
SHARES 111,400
BENEFICIALLY --------------------------------------------------------------
OWNED BY 6 SHARED VOTING POWER
EACH 0
REPORTING --------------------------------------------------------------
PERSON 7 SOLE DISPOSITIVE POWER
WITH 111,400
--------------------------------------------------------------
8 SHARED DISPOSITIVE POWER
0
----------------------------------------------------------------------------
9 AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
359,400
--------------------------------------------------------------------------------
10 CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES*
--------------------------------------------------------------------------------
11 PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
2.1%
--------------------------------------------------------------------------------
12 TYPE OF REPORTING PERSON*
IN
--------------------------------------------------------------------------------
*SEE INSTRUCTIONS BEFORE FILLING OUT
Page 4 of 6 Pages
Item 1. (a) Name of Issuer:
Exegenics Inc.
(b) Address of Issuer's Principal Executive Offices:
1250 Pittsford-Victor Road
Building 200, Suite 280
Pittsford, NY 14583
(585) 218-4368
Item 2. (a) Name of Person Filing:
J. Morton Davis and Rosalind Davidowitz. See Exhibit A
to the original Schedule 13G, which is a copy of their
agreement in writing to file this statement on behalf of
each of them.
(b) Address of Principal Business Office:
Mr. Davis' business address is 44 Wall Street, New
York, New York 10005. Mrs. Davidowitz's address is 7 Sutton
Place South, Lawrence, New York 11559.
(c) Citizenship:
Mr. Davis and Mrs. Davidowitz are United States
citizens.
(d) Title of Class of Securities:
Common Stock, $.01 par value ("shares")
(e) CUSIP Number:
301610101
Item 3. If this statement is filed pursuant to Rules 13d-1(b), or
13d-2(b), check whether the person filing is a:
(a) [ ] Broker or Dealer registered under Section 15 of the
Act
(b) [ ] Bank as defined in section 3(a)(6) of the Act
(c) [ ] Insurance Company as defined in section 3(a)(19) of
the Act
(d) [ ] Investment Company registered under section 8 of the
Investment Company Act
(e) [ ] Investment Adviser registered under section 203 of the
Investment Advisers Act of 1940
(f) [ ] Employee Benefit Plan, Pension Fund which is subject
to the provisions of the Employee Retirement Income
Security Act of 1974 or Endowment Fund; see Section
240.13d-1(b)(1)(ii)(F)
(g) [ ] Parent Holding Company, in accordance with Section
240.13d-1(b)(1)(ii)(G)
(h) [ ] Group, in accordance with Section 240.13d-
1(b)(1)(ii)(H)
(i) [ ] A church plan that is excluded from definition of an
investment company under section 3(c) (14) of the
Investment Company Act of 1940.
Page 5 of 6 Pages
Item 4. Ownership.
(a) (b) As of December 31, 2006, Mr. Davis may be deemed to
beneficially own 359,400 shares or 2.1% of the Issuer's shares
issued and outstanding as follows: (i) 248,000 shares owned by
D.H. Blair Investment Banking Corp. ("Blair Investment") (1), and
(ii) 111,400 shares owned by Rosalind Davidowitz (2).
As of December 31, 2005, Rosalind Davidowitz may be deemed to
beneficially own 359,400 shares or 2.1% of the Issuer's shares
issued and outstanding as follows: (i) 111,400 shares owned
directly by Rosalind Davidowitz, and (ii) 248,000 shares
owned by Blair Investment (1) (3).
(c) Mr. Davis has sole power to vote or to direct the vote, to
dispose or to direct the disposition of those shares owned by
Blair Investment. Ms. Davidowitz has sole power to vote or to
direct the disposition of those shares owned directly by her.
Item 5. Ownership of Five Percent or Less of a Class.
Mr. Davis and Mrs. Davidowitz each beneficially own less than 5% of
the shares of the Issuer.
Item 6. Ownership of More Than Five Percent on Behalf of Another Person.
Not applicable.
Item 7. Identification and Classification of the Subsidiary which Acquired
the Security Being Reported on By the Parent Holding Company.
Not applicable.
Item 8. Identification and Classification of Members of the Group.
Not applicable.
Item 9. Notice of Dissolution of Group.
Not applicable.
Item 10. Certification.
By signing below we certify that, to the best of our knowledge and belief,
the securities referred to above were acquired in the ordinary course of
business and were not acquired for the purpose of and do not have the effect of
changing or influencing the control of the issuer of such securities and were
not acquired in connection with or as a participant in any transaction having
such purpose or effect.
___________________________________________________________________________
(1) J. Morton Davis is the sole shareholder of Blair Investment, a broker-
dealer registered under the Securities Exchange Act of 1934.
(2) Rosalind Davidowitz is Mr. Davis' wife. Filing of this statement shall not
be deemed an admission by J. Morton Davis that he beneficially owns the
securities attributed to Rosalind Davidowitz for any purpose. J. Morton
Davis expressly disclaims beneficial ownership of all securities held by
Rosalind Davidowitz for any purpose.
(3) The filing of this statement shall not be deemed an admission by Rosalind
Davidowitz that she beneficially owns the securities attributed to Blair
Investment for any purpose. Rosalind Davidowitz expressly disclaims
beneficial ownership of all securities held by Blair Investment for any
purpose.
Page 6 of 6 pages
Signature.
After reasonable inquiry and to the best of our knowledge and belief, we
certify that the information set forth in this statement is true, complete and
correct.
Date: February 8, 2007
By: /s/ J. Morton Davis
-------------------------------
J. Morton Davis
Date: February 8, 2007
By: /s/ Rosalind Davidowitz
-------------------------------
Rosalind Davidowitz